Cargando…

The Human Gut Microbe Bacteroides thetaiotaomicron Suppresses Toxin Release from Clostridium difficile by Inhibiting Autolysis

Disruption of the human gut microbiota by antibiotics can lead to Clostridium difficile (CD)-associated diarrhea. CD overgrowth and elevated CD toxins result in gut inflammation. Herein, we report that a gut symbiont, Bacteroides thetaiotaomicron (BT), suppressed CD toxin production. The suppressive...

Descripción completa

Detalles Bibliográficos
Autores principales: Elahi, Miad, Nakayama-Imaohji, Haruyuki, Hashimoto, Masahito, Tada, Ayano, Yamasaki, Hisashi, Nagao, Tamiko, Kuwahara, Tomomi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7918992/
https://www.ncbi.nlm.nih.gov/pubmed/33671889
http://dx.doi.org/10.3390/antibiotics10020187
_version_ 1783658049053917184
author Elahi, Miad
Nakayama-Imaohji, Haruyuki
Hashimoto, Masahito
Tada, Ayano
Yamasaki, Hisashi
Nagao, Tamiko
Kuwahara, Tomomi
author_facet Elahi, Miad
Nakayama-Imaohji, Haruyuki
Hashimoto, Masahito
Tada, Ayano
Yamasaki, Hisashi
Nagao, Tamiko
Kuwahara, Tomomi
author_sort Elahi, Miad
collection PubMed
description Disruption of the human gut microbiota by antibiotics can lead to Clostridium difficile (CD)-associated diarrhea. CD overgrowth and elevated CD toxins result in gut inflammation. Herein, we report that a gut symbiont, Bacteroides thetaiotaomicron (BT), suppressed CD toxin production. The suppressive components are present in BT culture supernatant and are both heat- and proteinase K-resistant. Transposon-based mutagenesis indicated that the polysaccharide metabolism of BT is involved in the inhibitory effect. Among the genes identified, we focus on the methylerythritol 4-phosphate pathway gene gcpE, which supplies the isoprenoid backbone to produce the undecaprenyl phosphate lipid carrier that transports oligosaccharides across the membrane. Polysaccharide fractions prepared from the BT culture suppressed CD toxin production in vitro; the inhibitory effect of polysaccharide fractions was reduced in the gcpE mutant (ΔgcpE). The inhibitory effect of BT-derived polysaccharide fraction was abrogated by lysozyme treatment, indicating that cellwall-associated glycans are attributable to the inhibitory effect. BT-derived polysaccharide fraction did not affect CD toxin gene expression or intracellular toxin levels. An autolysis assay showed that CD cell autolysis was suppressed by BT-derived polysaccharide fraction, but the effect was reduced with that of ΔgcpE. These results indicate that cell wall-associated glycans of BT suppress CD toxin release by inhibiting cell autolysis.
format Online
Article
Text
id pubmed-7918992
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-79189922021-03-02 The Human Gut Microbe Bacteroides thetaiotaomicron Suppresses Toxin Release from Clostridium difficile by Inhibiting Autolysis Elahi, Miad Nakayama-Imaohji, Haruyuki Hashimoto, Masahito Tada, Ayano Yamasaki, Hisashi Nagao, Tamiko Kuwahara, Tomomi Antibiotics (Basel) Article Disruption of the human gut microbiota by antibiotics can lead to Clostridium difficile (CD)-associated diarrhea. CD overgrowth and elevated CD toxins result in gut inflammation. Herein, we report that a gut symbiont, Bacteroides thetaiotaomicron (BT), suppressed CD toxin production. The suppressive components are present in BT culture supernatant and are both heat- and proteinase K-resistant. Transposon-based mutagenesis indicated that the polysaccharide metabolism of BT is involved in the inhibitory effect. Among the genes identified, we focus on the methylerythritol 4-phosphate pathway gene gcpE, which supplies the isoprenoid backbone to produce the undecaprenyl phosphate lipid carrier that transports oligosaccharides across the membrane. Polysaccharide fractions prepared from the BT culture suppressed CD toxin production in vitro; the inhibitory effect of polysaccharide fractions was reduced in the gcpE mutant (ΔgcpE). The inhibitory effect of BT-derived polysaccharide fraction was abrogated by lysozyme treatment, indicating that cellwall-associated glycans are attributable to the inhibitory effect. BT-derived polysaccharide fraction did not affect CD toxin gene expression or intracellular toxin levels. An autolysis assay showed that CD cell autolysis was suppressed by BT-derived polysaccharide fraction, but the effect was reduced with that of ΔgcpE. These results indicate that cell wall-associated glycans of BT suppress CD toxin release by inhibiting cell autolysis. MDPI 2021-02-15 /pmc/articles/PMC7918992/ /pubmed/33671889 http://dx.doi.org/10.3390/antibiotics10020187 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Elahi, Miad
Nakayama-Imaohji, Haruyuki
Hashimoto, Masahito
Tada, Ayano
Yamasaki, Hisashi
Nagao, Tamiko
Kuwahara, Tomomi
The Human Gut Microbe Bacteroides thetaiotaomicron Suppresses Toxin Release from Clostridium difficile by Inhibiting Autolysis
title The Human Gut Microbe Bacteroides thetaiotaomicron Suppresses Toxin Release from Clostridium difficile by Inhibiting Autolysis
title_full The Human Gut Microbe Bacteroides thetaiotaomicron Suppresses Toxin Release from Clostridium difficile by Inhibiting Autolysis
title_fullStr The Human Gut Microbe Bacteroides thetaiotaomicron Suppresses Toxin Release from Clostridium difficile by Inhibiting Autolysis
title_full_unstemmed The Human Gut Microbe Bacteroides thetaiotaomicron Suppresses Toxin Release from Clostridium difficile by Inhibiting Autolysis
title_short The Human Gut Microbe Bacteroides thetaiotaomicron Suppresses Toxin Release from Clostridium difficile by Inhibiting Autolysis
title_sort human gut microbe bacteroides thetaiotaomicron suppresses toxin release from clostridium difficile by inhibiting autolysis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7918992/
https://www.ncbi.nlm.nih.gov/pubmed/33671889
http://dx.doi.org/10.3390/antibiotics10020187
work_keys_str_mv AT elahimiad thehumangutmicrobebacteroidesthetaiotaomicronsuppressestoxinreleasefromclostridiumdifficilebyinhibitingautolysis
AT nakayamaimaohjiharuyuki thehumangutmicrobebacteroidesthetaiotaomicronsuppressestoxinreleasefromclostridiumdifficilebyinhibitingautolysis
AT hashimotomasahito thehumangutmicrobebacteroidesthetaiotaomicronsuppressestoxinreleasefromclostridiumdifficilebyinhibitingautolysis
AT tadaayano thehumangutmicrobebacteroidesthetaiotaomicronsuppressestoxinreleasefromclostridiumdifficilebyinhibitingautolysis
AT yamasakihisashi thehumangutmicrobebacteroidesthetaiotaomicronsuppressestoxinreleasefromclostridiumdifficilebyinhibitingautolysis
AT nagaotamiko thehumangutmicrobebacteroidesthetaiotaomicronsuppressestoxinreleasefromclostridiumdifficilebyinhibitingautolysis
AT kuwaharatomomi thehumangutmicrobebacteroidesthetaiotaomicronsuppressestoxinreleasefromclostridiumdifficilebyinhibitingautolysis
AT elahimiad humangutmicrobebacteroidesthetaiotaomicronsuppressestoxinreleasefromclostridiumdifficilebyinhibitingautolysis
AT nakayamaimaohjiharuyuki humangutmicrobebacteroidesthetaiotaomicronsuppressestoxinreleasefromclostridiumdifficilebyinhibitingautolysis
AT hashimotomasahito humangutmicrobebacteroidesthetaiotaomicronsuppressestoxinreleasefromclostridiumdifficilebyinhibitingautolysis
AT tadaayano humangutmicrobebacteroidesthetaiotaomicronsuppressestoxinreleasefromclostridiumdifficilebyinhibitingautolysis
AT yamasakihisashi humangutmicrobebacteroidesthetaiotaomicronsuppressestoxinreleasefromclostridiumdifficilebyinhibitingautolysis
AT nagaotamiko humangutmicrobebacteroidesthetaiotaomicronsuppressestoxinreleasefromclostridiumdifficilebyinhibitingautolysis
AT kuwaharatomomi humangutmicrobebacteroidesthetaiotaomicronsuppressestoxinreleasefromclostridiumdifficilebyinhibitingautolysis